Cargando…
Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease
BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disorder with no absolute cure. The evidence of the involvement of gut microbiota in PD pathogenesis suggests the need to identify certain molecule(s) derived from the gut microbiota, which has the potential to manage PD. Osteocalcin (OCN),...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849090/ https://www.ncbi.nlm.nih.gov/pubmed/33517890 http://dx.doi.org/10.1186/s40168-020-00988-6 |
_version_ | 1783645246513479680 |
---|---|
author | Hou, Yan-fang Shan, Chang Zhuang, Si-yue Zhuang, Qian-qian Ghosh, Arijit Zhu, Ke-cheng Kong, Xiao-ke Wang, Shu-min Gong, Yan-ling Yang, Yu-ying Tao, Bei Sun, Li-hao Zhao, Hong-Yan Guo, Xing-zhi Wang, Wei-qing Ning, Guang Gu, Yan-yun Li, Sheng-tian Liu, Jian-min |
author_facet | Hou, Yan-fang Shan, Chang Zhuang, Si-yue Zhuang, Qian-qian Ghosh, Arijit Zhu, Ke-cheng Kong, Xiao-ke Wang, Shu-min Gong, Yan-ling Yang, Yu-ying Tao, Bei Sun, Li-hao Zhao, Hong-Yan Guo, Xing-zhi Wang, Wei-qing Ning, Guang Gu, Yan-yun Li, Sheng-tian Liu, Jian-min |
author_sort | Hou, Yan-fang |
collection | PubMed |
description | BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disorder with no absolute cure. The evidence of the involvement of gut microbiota in PD pathogenesis suggests the need to identify certain molecule(s) derived from the gut microbiota, which has the potential to manage PD. Osteocalcin (OCN), an osteoblast-secreted protein, has been shown to modulate brain function. Thus, it is of interest to investigate whether OCN could exert protective effect on PD and, if yes, whether the underlying mechanism lies in the subsequent changes in gut microbiota. RESULTS: The intraperitoneal injection of OCN can effectively ameliorate the motor deficits and dopaminergic neuronal loss in a 6-hydroxydopamine-induced PD mouse model. The further antibiotics treatment and fecal microbiota transplantation experiments confirmed that the gut microbiota was required for OCN-induced protection in PD mice. OCN elevated Bacteroidetes and depleted Firmicutes phyla in the gut microbiota of PD mice with elevated potential of microbial propionate production and was confirmed by fecal propionate levels. Two months of orally administered propionate successfully rescued motor deficits and dopaminergic neuronal loss in PD mice. Furthermore, AR420626, the agonist of FFAR3, which is the receptor of propionate, mimicked the neuroprotective effects of propionate and the ablation of enteric neurons blocked the prevention of dopaminergic neuronal loss by propionate in PD mice. CONCLUSIONS: Together, our results demonstrate that OCN ameliorates motor deficits and dopaminergic neuronal loss in PD mice, modulating gut microbiome and increasing propionate level might be an underlying mechanism responsible for the neuroprotective effects of OCN on PD, and the FFAR3, expressed in enteric nervous system, might be the main action site of propionate. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40168-020-00988-6. |
format | Online Article Text |
id | pubmed-7849090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78490902021-02-03 Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease Hou, Yan-fang Shan, Chang Zhuang, Si-yue Zhuang, Qian-qian Ghosh, Arijit Zhu, Ke-cheng Kong, Xiao-ke Wang, Shu-min Gong, Yan-ling Yang, Yu-ying Tao, Bei Sun, Li-hao Zhao, Hong-Yan Guo, Xing-zhi Wang, Wei-qing Ning, Guang Gu, Yan-yun Li, Sheng-tian Liu, Jian-min Microbiome Research BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disorder with no absolute cure. The evidence of the involvement of gut microbiota in PD pathogenesis suggests the need to identify certain molecule(s) derived from the gut microbiota, which has the potential to manage PD. Osteocalcin (OCN), an osteoblast-secreted protein, has been shown to modulate brain function. Thus, it is of interest to investigate whether OCN could exert protective effect on PD and, if yes, whether the underlying mechanism lies in the subsequent changes in gut microbiota. RESULTS: The intraperitoneal injection of OCN can effectively ameliorate the motor deficits and dopaminergic neuronal loss in a 6-hydroxydopamine-induced PD mouse model. The further antibiotics treatment and fecal microbiota transplantation experiments confirmed that the gut microbiota was required for OCN-induced protection in PD mice. OCN elevated Bacteroidetes and depleted Firmicutes phyla in the gut microbiota of PD mice with elevated potential of microbial propionate production and was confirmed by fecal propionate levels. Two months of orally administered propionate successfully rescued motor deficits and dopaminergic neuronal loss in PD mice. Furthermore, AR420626, the agonist of FFAR3, which is the receptor of propionate, mimicked the neuroprotective effects of propionate and the ablation of enteric neurons blocked the prevention of dopaminergic neuronal loss by propionate in PD mice. CONCLUSIONS: Together, our results demonstrate that OCN ameliorates motor deficits and dopaminergic neuronal loss in PD mice, modulating gut microbiome and increasing propionate level might be an underlying mechanism responsible for the neuroprotective effects of OCN on PD, and the FFAR3, expressed in enteric nervous system, might be the main action site of propionate. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40168-020-00988-6. BioMed Central 2021-01-31 /pmc/articles/PMC7849090/ /pubmed/33517890 http://dx.doi.org/10.1186/s40168-020-00988-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Hou, Yan-fang Shan, Chang Zhuang, Si-yue Zhuang, Qian-qian Ghosh, Arijit Zhu, Ke-cheng Kong, Xiao-ke Wang, Shu-min Gong, Yan-ling Yang, Yu-ying Tao, Bei Sun, Li-hao Zhao, Hong-Yan Guo, Xing-zhi Wang, Wei-qing Ning, Guang Gu, Yan-yun Li, Sheng-tian Liu, Jian-min Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease |
title | Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease |
title_full | Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease |
title_fullStr | Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease |
title_full_unstemmed | Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease |
title_short | Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease |
title_sort | gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of parkinson’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849090/ https://www.ncbi.nlm.nih.gov/pubmed/33517890 http://dx.doi.org/10.1186/s40168-020-00988-6 |
work_keys_str_mv | AT houyanfang gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT shanchang gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT zhuangsiyue gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT zhuangqianqian gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT ghosharijit gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT zhukecheng gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT kongxiaoke gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT wangshumin gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT gongyanling gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT yangyuying gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT taobei gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT sunlihao gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT zhaohongyan gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT guoxingzhi gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT wangweiqing gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT ningguang gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT guyanyun gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT lishengtian gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease AT liujianmin gutmicrobiotaderivedpropionatemediatestheneuroprotectiveeffectofosteocalcininamousemodelofparkinsonsdisease |